BIOAGE LABS INC. O.N.
BIOAGE LABS INC. O.N.
Share · US09077V1008 · BIOA · A40D7P (XNAS)
Overview
No Price
11.09.2025 14:58
1 day
-
1 week
-
1 month
-
3 months
-
6 months
-
Year to date
-
1 year
-
2 years
-
3 years
-
4 years
-
5 years
-
10 years
-
20 years
-
Max
-
Analyst Grade Summary
gauge-img
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell
0
0
2
0
0
Current Prices from BIOAGE LABS INC. O.N.
ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
BIOA
USD
11.09.2025 14:58
4,97 USD
0,14 USD
+3,01 %
ESG Risk Rating
B Good
Share Float & Liquidity
Free Float 58,71 %
Shares Float 21,05 M
Shares Outstanding 35,85 M
Company Profile for BIOAGE LABS INC. O.N. Share
BioAge Labs, Inc. is a clinical-stage biopharmaceutical company that develops therapeutic product candidates for metabolic diseases. The company's technology platform and differentiated human datasets allows users to identify targets based on insights into molecular changes that drive aging. Its product includes azelaprag, an orally available small molecule that is in phase 1 clinical trial for the treatment of obesity; and initiated phase 2 clinical trial of azelaprag in combination with tirzepatide for the treatment of obesity in older adults. It also develops BGE-100, an orally available small molecule brain-penetrant NLRP3 antagonist for the treatment of diseases driven by neuroinflammation. The company was incorporated in 2015 and is based in Richmond, California.

Company Data

Name BIOAGE LABS INC. O.N.
Company BioAge Labs, Inc.
Symbol BIOA
Website https://bioagelabs.com
Primary Exchange XNAS Frankfurt
WKN A40D7P
ISIN US09077V1008
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Kristen Fortney
Market Capitalization 158 Mio
Country United States of America
Currency EUR
Employees 0,1 T
Address 1445A South 50th Street, 94804 Richmond
IPO Date 2024-09-26

Ticker Symbols

Name Symbol
Frankfurt Y7G.F
NASDAQ BIOA
More Shares
Investors who hold BIOAGE LABS INC. O.N. also have the following shares in their portfolio:
FIRM.PRO.PA. 20/26 REGS
FIRM.PRO.PA. 20/26 REGS Bond
ONCOZENGE AB
ONCOZENGE AB Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025